Endometrioid Ovarian Cancer
4 clinical trials · Condition
◉ Watch Endometrioid Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer (NCT06856499) | University of Colorado, Denver | 2025-12-08 |
| CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. (NCT06690775) | TORL Biotherapeutics, LLC | 2024-11-20 |
| Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) (NCT05281471) | Genelux Corporation | 2022-08-31 |
| A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers (NCT05403554) | Light Chain Bioscience - Novimmune SA | 2022-04-29 |
Track Endometrioid Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.